U.S. Orthopedic Implants Market Size, Share, Analysis, By Product (Joint Reconstruction {Knee, Hip, and Extremities}, Spinal Implants {Spinal Fusion Devices and Spinal Non-fusion Devices}, Trauma Implants, and Others)), By End-user (Hospitals & Ambulatory Surgery Centers, and Orthopedic Clinics & Others), and Country Forecast, 2024-2032

The U.S. orthopedic implants market size was worth USD 22.98 billion in 2023 and is anticipated to grow at a CAGR of 5.0% during the forecast period. 

Orthopedic implants are prosthetic or synthetic devices that replace or support damaged bones, joints, and other skeletal body parts. They are made up of different materials including ceramic, polymer, and metallic alloys, and are designed to mimic the function of the natural anatomy of the human body.

The rising prevalence of co-morbid conditions such as obesity is leading to higher incidents of joint degeneration and arthritis. This along with the increasing incidence of diseases such as osteoporosis is presenting a large patient pool undergoing joint replacement surgeries. This is contributing to increased demand for these implants.

• For instance, according to an article published in September 2022 by Trust for America's Health, 4 out of 10 American adults were obese in 2021 and the obesity rates are increasing persistently. The same report revealed that 19 states have adult obesity rates over 35.0%, up from 16 states in 2020.

The impact of COVID-19 on the market was negative in 2020, owing to the cancellation of elective surgical procedures, leading to a decline in sales of orthopedic implants in the country. However, the services resumed in 2021, and the subsequent demand for these implants has seen considerable growth.

LATEST TRENDS

Growing Trend and Focus on Smart Orthopedic Implants to Spur Market Growth

With the help of embedded sensors, smart implants provide real-time information related to implant positioning during the surgical procedure as well as postoperative evaluation leading to enhanced outcomes of the procedures. Smart implants have applications in knee arthroplasty, hip arthroplasty, spine fusion, and other procedures. These implants provide valuable information related to infection detection, early dislocation detection, bone ingrowth measurement, spine fusion detection, fracture healing measurement, and early detection of osteolysis, among others. This new technology is gaining widespread attention from surgeons and patients, encouraging the market players to develop such innovative products.

• For instance, in January 2021, Stryker announced the acquisition of OrthoSensor, Inc., with an aim to innovate its devices by incorporating the latter company’s sensor technology and data services. OrthoSensor, Inc., is specialized in sensor technology for total joint replacements.

DRIVING FACTORS

Rapidly Growing Geriatric Population to Boost Demand for Orthopedic Implants

The rising prevalence of age-related conditions, including musculoskeletal conditions such as arthritis, osteoporosis, and fractures, is presenting a large patient pool requiring treatment. Furthermore, the country is witnessing a gradual rise in the geriatric population. These factors are propelling the demand for technologically advanced implants in the country.

• According to the Bone Health & Osteoporosis Foundation, around 10 million people in the U.S. suffer from osteoporosis and around 44 million people have low bone density.


• According to a report published in November 2022 by the American Joint Replacement Registry (AJRR), around 2,550,232 primary and revision hip and knee arthroplasty procedures were performed from 2012 to 2021.

Thus, the increasing number of joint replacement procedures are anticipated to fuel U.S. orthopedic implants market growth during the forecast period.

RESTRAINING FACTORS

High Chance of Implant Infection to Limit the Product Adoption and Market Growth 

Infections related to orthopedic implants mainly occur due to microbial adhesion on the implant surface. Staphylococcus comprise around 2/3^rd of all pathogens in orthopedic implant infections leading to chances of implant failure. The chances of infection depend on various factors such as the patient’s health, surgical technique, postoperative care, defect in implant packaging, and improper sterility.

Thus, the rising cases of orthopedic implant infection are leading to a preference for alternative treatments being preferred, thereby limiting the demand for these implants.

• For instance, according to an article published in October 2022, in Elsevier B.V., one of the major infections associated with orthopedic implants is Osteomyelitis. It is developed due to pathogen invasion on the implant surface during surgery.

SEGMENTATION

By Product Analysis

Based on product, the market is categorized into spinal implants, trauma implants, joint reconstruction, and others.                                                                           

In 2022, the joint reconstruction segment held the major U.S. orthopedic implants market share. The dominance is attributed to the rising number of hip and knee arthroplasty procedures in the U.S.

The increasing number of trauma cases and sports injuries in the country is presenting a large number of patients undergoing surgical procedures. This is anticipated to drive the growth of the trauma segment during the forecast period.

• In April 2023, Bioretec Ltd., received the U.S. FDA approval with market authorization for its RemeOs trauma screw in the U.S. The RemeOs trauma screw is a bioresorbable metal implant that covers several indications, including ankle fractures. The company would launch the product in collaboration with hospitals and clinics specializing in ankle fractures.

By End User Analysis

Based on end user, the market is categorized into specialty clinics, hospitals & ambulatory surgery centers, and others.

The hospitals & ambulatory surgery centers segment held a major market share in 2022 owing to a higher number of procedures performed in these settings. A few factors such as higher adoption of advanced technologies and a well-established healthcare infrastructure to perform the surgery. In addition, their ability to handle potential complications is further responsible for the comparatively higher procedure share of these settings.

This along with the rising adoption of robot assisted surgeries by hospitals & ambulatory surgery centers in the U.S., has been pivotal in increasing preference of patients toward these settings for joint replacement and other orthopedic surgeries. This has further bolstered the segment dominance in the market.

KEY INDUSTRY PLAYERS

The high R&D expenditure by key market players leading to the development and introduction of new products is one of the major factors propelling the market growth. Key market players such as Stryker, DePuy Synthes (Johnson & Johnson Services, Inc.), Zimmer Biomet, and Smith & Nephew have solidified their position through a wide product portfolio, strong distribution network, penetrated presence, and strategic alliances.

For instance, in May 2023, Zimmer Biomet entered an agreement and announced plans to acquire OSSIS Corporation, a privately held 3D printed orthopedic implants manufacturer. The acquisition is aimed at expanding the product portfolio of Zimmer Biomet.

Moreover, growing opportunities for new market entrants are further creating a dynamic market landscape and are anticipated to support the growth of these players during the forecast period.

LIST OF KEY COMPANIES PROFILED:

• Zimmer Biomet (U.S.)


• Johnson & Johnson Medical Devices (U.S.)


• Smith+Nephew (U.K.)


• Stryker (U.S.)


• BioTek (U.S.)


• CONMED Corporation (U.S.)


• Medtronic (Ireland)


• Enovis (Formerly DJO Surgical) (U.S.)


• Exactech, Inc. (U.S.)


• Corin Group (U.K.)


• Conformis (U.S.)


• Globus Medical (U.S.)

KEY INDUSTRY DEVELOPMENTS: 

• November 2022 – Zimmer Biomet received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Persona OsseoTi Keel Tibia. The product would be a part of the Persona Knee System and would allow surgeons to fulfill the need of patients demand for cementless knee replacement.


• November 2022 – Exactech, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for TriVerse, a primary knee system. The launch of TriVerse would contribute to the company’s knee solutions portfolio.


• August 2021 – Enovis (Formerly DJO Surgical) announced the launch of EMPOWR Dual Mobility, at the 2021 American Academy of Orthopaedic Surgeons (AAOS) annual meeting. EMPOWR Dual Mobility is a comprehensive hip implant for both revision and primary total hip arthroplasty procedures.

REPORT COVERAGE

The U.S. market report provides a detailed market analysis. It focuses on key aspects such as technological advancement and emerging trends in medical clothing. Additionally, U.S. orthopedic implants market forecast report includes new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. Besides this, the report also highlights key industry dynamics.

Report Scope & Segmentation